<!-- KEYWORD_LINKING_METADATA:
{
  "processed_timestamp": "2025-09-24T14:18:14.484381",
  "vocabulary_version": "1.0",
  "selected_keywords": [
    "Segment Anything Model",
    "Transformer",
    "Neurofibromatosis type 1",
    "Whole-body MRI",
    "Exemplar-based semantic propagation"
  ],
  "rejected_keywords": [],
  "similarity_scores": {
    "Segment Anything Model": 0.78,
    "Transformer": 0.85,
    "Neurofibromatosis type 1": 0.8,
    "Whole-body MRI": 0.77,
    "Exemplar-based semantic propagation": 0.75
  },
  "extraction_method": "AI_prompt_based",
  "budget_applied": true,
  "candidates_json": {
    "candidates": [
      {
        "surface": "Segment Anything Model 2",
        "canonical": "Segment Anything Model",
        "aliases": [
          "SAM2"
        ],
        "category": "unique_technical",
        "rationale": "A novel model for interactive segmentation, crucial for linking advancements in segmentation technologies.",
        "novelty_score": 0.85,
        "connectivity_score": 0.7,
        "specificity_score": 0.8,
        "link_intent_score": 0.78
      },
      {
        "surface": "Transformer-based",
        "canonical": "Transformer",
        "aliases": [],
        "category": "broad_technical",
        "rationale": "Transformers are a foundational technology in modern machine learning models, enabling connections to related works.",
        "novelty_score": 0.3,
        "connectivity_score": 0.9,
        "specificity_score": 0.6,
        "link_intent_score": 0.85
      },
      {
        "surface": "Neurofibromatosis type 1",
        "canonical": "Neurofibromatosis type 1",
        "aliases": [
          "NF1"
        ],
        "category": "unique_technical",
        "rationale": "A specific medical condition that is central to the study, linking to medical literature on genetic disorders.",
        "novelty_score": 0.7,
        "connectivity_score": 0.65,
        "specificity_score": 0.9,
        "link_intent_score": 0.8
      },
      {
        "surface": "Whole-body MRI",
        "canonical": "Whole-body MRI",
        "aliases": [
          "WB-MRI"
        ],
        "category": "unique_technical",
        "rationale": "A specific imaging technique essential for the study, facilitating connections to imaging and diagnostic research.",
        "novelty_score": 0.65,
        "connectivity_score": 0.75,
        "specificity_score": 0.85,
        "link_intent_score": 0.77
      },
      {
        "surface": "Exemplar-based semantic propagation",
        "canonical": "Exemplar-based semantic propagation",
        "aliases": [],
        "category": "unique_technical",
        "rationale": "A novel method introduced in the study, providing a link to advancements in semantic segmentation techniques.",
        "novelty_score": 0.8,
        "connectivity_score": 0.6,
        "specificity_score": 0.88,
        "link_intent_score": 0.75
      }
    ],
    "ban_list_suggestions": [
      "interactive segmentation",
      "lesion detection"
    ]
  },
  "decisions": [
    {
      "candidate_surface": "Segment Anything Model 2",
      "resolved_canonical": "Segment Anything Model",
      "decision": "linked",
      "scores": {
        "novelty": 0.85,
        "connectivity": 0.7,
        "specificity": 0.8,
        "link_intent": 0.78
      }
    },
    {
      "candidate_surface": "Transformer-based",
      "resolved_canonical": "Transformer",
      "decision": "linked",
      "scores": {
        "novelty": 0.3,
        "connectivity": 0.9,
        "specificity": 0.6,
        "link_intent": 0.85
      }
    },
    {
      "candidate_surface": "Neurofibromatosis type 1",
      "resolved_canonical": "Neurofibromatosis type 1",
      "decision": "linked",
      "scores": {
        "novelty": 0.7,
        "connectivity": 0.65,
        "specificity": 0.9,
        "link_intent": 0.8
      }
    },
    {
      "candidate_surface": "Whole-body MRI",
      "resolved_canonical": "Whole-body MRI",
      "decision": "linked",
      "scores": {
        "novelty": 0.65,
        "connectivity": 0.75,
        "specificity": 0.85,
        "link_intent": 0.77
      }
    },
    {
      "candidate_surface": "Exemplar-based semantic propagation",
      "resolved_canonical": "Exemplar-based semantic propagation",
      "decision": "linked",
      "scores": {
        "novelty": 0.8,
        "connectivity": 0.6,
        "specificity": 0.88,
        "link_intent": 0.75
      }
    }
  ]
}
-->

# MOIS-SAM2: Exemplar-based Segment Anything Model 2 for multilesion interactive segmentation of neurobromas in whole-body MRI

## ğŸ“‹ ë©”íƒ€ë°ì´í„°

**Links**: [[daily_digest_20250924|20250924]] [[categories/cs.AI|cs.AI]]
**PDF**: [Download](https://arxiv.org/pdf/2509.19277.pdf)
**Category**: cs.AI
**Published**: 2025-09-24
**ArXiv ID**: [2509.19277](https://arxiv.org/abs/2509.19277)

## ğŸ”— ìœ ì‚¬í•œ ë…¼ë¬¸
- [[2025-09-22/ENSAM_ an efficient foundation model for interactive segmentation of 3D medical images_20250922|ENSAM: an efficient foundation model for interactive segmentation of 3D medical images]] (85.0% similar)
- [[2025-09-23/SAM-DCE_ Addressing Token Uniformity and Semantic Over-Smoothing in Medical Segmentation_20250923|SAM-DCE: Addressing Token Uniformity and Semantic Over-Smoothing in Medical Segmentation]] (84.3% similar)
- [[2025-09-22/pFedSAM_ Personalized Federated Learning of Segment Anything Model for Medical Image Segmentation_20250922|pFedSAM: Personalized Federated Learning of Segment Anything Model for Medical Image Segmentation]] (84.1% similar)
- [[2025-09-23/Unified Multimodal Coherent Field_ Synchronous Semantic-Spatial-Vision Fusion for Brain Tumor Segmentation_20250923|Unified Multimodal Coherent Field: Synchronous Semantic-Spatial-Vision Fusion for Brain Tumor Segmentation]] (83.3% similar)
- [[2025-09-22/NeuroRAD-FM_ A Foundation Model for Neuro-Oncology with Distributionally Robust Training_20250922|NeuroRAD-FM: A Foundation Model for Neuro-Oncology with Distributionally Robust Training]] (82.9% similar)

## ğŸ·ï¸ ì¹´í…Œê³ ë¦¬í™”ëœ í‚¤ì›Œë“œ
**ğŸ§  Broad Technical**: [[keywords/Transformer|Transformer]]
**âš¡ Unique Technical**: [[keywords/Segment Anything Model|Segment Anything Model]], [[keywords/Neurofibromatosis type 1|Neurofibromatosis type 1]], [[keywords/Whole-body MRI|Whole-body MRI]], [[keywords/Exemplar-based semantic propagation|Exemplar-based semantic propagation]]

## ğŸ“‹ ì €ì ì •ë³´

**Authors:** 

## ğŸ“„ Abstract (ì›ë¬¸)

arXiv:2509.19277v1 Announce Type: cross 
Abstract: Background and Objectives: Neurofibromatosis type 1 is a genetic disorder characterized by the development of numerous neurofibromas (NFs) throughout the body. Whole-body MRI (WB-MRI) is the clinical standard for detection and longitudinal surveillance of NF tumor growth. Existing interactive segmentation methods fail to combine high lesion-wise precision with scalability to hundreds of lesions. This study proposes a novel interactive segmentation model tailored to this challenge.
  Methods: We introduce MOIS-SAM2, a multi-object interactive segmentation model that extends the state-of-the-art, transformer-based, promptable Segment Anything Model 2 (SAM2) with exemplar-based semantic propagation. MOIS-SAM2 was trained and evaluated on 119 WB-MRI scans from 84 NF1 patients acquired using T2-weighted fat-suppressed sequences. The dataset was split at the patient level into a training set and four test sets (one in-domain and three reflecting different domain shift scenarios, e.g., MRI field strength variation, low tumor burden, differences in clinical site and scanner vendor).
  Results: On the in-domain test set, MOIS-SAM2 achieved a scan-wise DSC of 0.60 against expert manual annotations, outperforming baseline 3D nnU-Net (DSC: 0.54) and SAM2 (DSC: 0.35). Performance of the proposed model was maintained under MRI field strength shift (DSC: 0.53) and scanner vendor variation (DSC: 0.50), and improved in low tumor burden cases (DSC: 0.61). Lesion detection F1 scores ranged from 0.62 to 0.78 across test sets. Preliminary inter-reader variability analysis showed model-to-expert agreement (DSC: 0.62-0.68), comparable to inter-expert agreement (DSC: 0.57-0.69).
  Conclusions: The proposed MOIS-SAM2 enables efficient and scalable interactive segmentation of NFs in WB-MRI with minimal user input and strong generalization, supporting integration into clinical workflows.

## ğŸ“ ìš”ì•½

ì´ ì—°êµ¬ëŠ” ì‹ ê²½ì„¬ìœ ì¢…ì¦ 1í˜•(NF1)ì˜ ì¢…ì–‘ì„ íš¨ê³¼ì ìœ¼ë¡œ ë¶„í• í•˜ê¸° ìœ„í•œ ìƒˆë¡œìš´ ìƒí˜¸ì‘ìš©ì  ì„¸ë¶„í™” ëª¨ë¸ MOIS-SAM2ë¥¼ ì œì•ˆí•©ë‹ˆë‹¤. MOIS-SAM2ëŠ” ìµœì‹  íŠ¸ëœìŠ¤í¬ë¨¸ ê¸°ë°˜ì˜ Segment Anything Model 2(SAM2)ë¥¼ í™•ì¥í•˜ì—¬ ì˜ˆì œ ê¸°ë°˜ì˜ ì˜ë¯¸ ì „íŒŒë¥¼ ë„ì…í–ˆìŠµë‹ˆë‹¤. 84ëª…ì˜ NF1 í™˜ìì—ê²Œì„œ ì–»ì€ 119ê°œì˜ ì „ì‹  MRI ë°ì´í„°ë¥¼ ì‚¬ìš©í•˜ì—¬ ëª¨ë¸ì„ í›ˆë ¨ ë° í‰ê°€í–ˆìŠµë‹ˆë‹¤. ê²°ê³¼ì ìœ¼ë¡œ, MOIS-SAM2ëŠ” ì „ë¬¸ê°€ ìˆ˜ë™ ì£¼ì„ ëŒ€ë¹„ 0.60ì˜ DSCë¥¼ ê¸°ë¡í•˜ë©° ê¸°ì¡´ ëª¨ë¸ì„ ëŠ¥ê°€í–ˆìŠµë‹ˆë‹¤. ë˜í•œ, ë‹¤ì–‘í•œ MRI ì¡°ê±´ì—ì„œë„ ë†’ì€ ì„±ëŠ¥ì„ ìœ ì§€í•˜ë©°, ì„ìƒì  ì ìš© ê°€ëŠ¥ì„±ì„ ë³´ì—¬ì¤ë‹ˆë‹¤.

## ğŸ¯ ì£¼ìš” í¬ì¸íŠ¸

- 1. MOIS-SAM2ëŠ” ì‹ ê²½ì„¬ìœ ì¢…ì¦ 1í˜• í™˜ìì˜ ì „ì‹  MRIì—ì„œ ì‹ ê²½ì„¬ìœ ì¢…ì„ íš¨ìœ¨ì ìœ¼ë¡œ ë¶„í• í•˜ëŠ” ìƒˆë¡œìš´ ìƒí˜¸ì‘ìš© ëª¨ë¸ì…ë‹ˆë‹¤.
- 2. MOIS-SAM2ëŠ” ê¸°ì¡´ì˜ SAM2 ëª¨ë¸ì„ í™•ì¥í•˜ì—¬ ì˜ˆì‹œ ê¸°ë°˜ì˜ ì˜ë¯¸ ì „íŒŒë¥¼ í†µí•´ ë†’ì€ ì •í™•ë„ì˜ ë‹¤ì¤‘ ê°ì²´ ë¶„í• ì„ ê°€ëŠ¥í•˜ê²Œ í•©ë‹ˆë‹¤.
- 3. ì´ ëª¨ë¸ì€ ë‹¤ì–‘í•œ ë„ë©”ì¸ ë³€í™” ì‹œë‚˜ë¦¬ì˜¤ì—ì„œë„ ë†’ì€ ì„±ëŠ¥ì„ ìœ ì§€í•˜ë©°, íŠ¹íˆ ë‚®ì€ ì¢…ì–‘ ë¶€ë‹´ ì‚¬ë¡€ì—ì„œ ì„±ëŠ¥ì´ ê°œì„ ë˜ì—ˆìŠµë‹ˆë‹¤.
- 4. MOIS-SAM2ëŠ” ì „ë¬¸ê°€ ê°„ ì¼ì¹˜ë„ì™€ ìœ ì‚¬í•œ ìˆ˜ì¤€ì˜ ëª¨ë¸-ì „ë¬¸ê°€ ì¼ì¹˜ë„ë¥¼ ë³´ì—¬ì¤ë‹ˆë‹¤.
- 5. ì´ ëª¨ë¸ì€ ìµœì†Œí•œì˜ ì‚¬ìš©ì ì…ë ¥ìœ¼ë¡œ ì„ìƒ ì›Œí¬í”Œë¡œì— í†µí•©ë  ìˆ˜ ìˆëŠ” ê°•ë ¥í•œ ì¼ë°˜í™” ëŠ¥ë ¥ì„ ì œê³µí•©ë‹ˆë‹¤.


---

*Generated on 2025-09-24 14:18:14*